452 related articles for article (PubMed ID: 17133608)
21. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
22. Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22).
Chew GY; Sinha U; Gatenby PA; DeMalmanche T; Adelstein S; Garsia R; Hissaria P; French MA; Wilson A; Whittle B; Kirkpatrick P; Riminton DS; Fulcher DA; Cook MC
J Allergy Clin Immunol; 2013 Apr; 131(4):1130-5, 1135.e1. PubMed ID: 22857794
[TBL] [Abstract][Full Text] [Related]
23. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
Ueki A; Isozaki Y; Tomokuni A; Ueki H; Kusaka M; Tanaka S; Otsuki T; Sakaguchi H; Hyodoh F
Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
[TBL] [Abstract][Full Text] [Related]
24. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.
Orozco G; Sánchez E; González-Gay MA; López-Nevot MA; Torres B; Cáliz R; Ortego-Centeno N; Jiménez-Alonso J; Pascual-Salcedo D; Balsa A; de Pablo R; Nuñez-Roldan A; González-Escribano MF; Martín J
Arthritis Rheum; 2005 Jan; 52(1):219-24. PubMed ID: 15641066
[TBL] [Abstract][Full Text] [Related]
25. Association of PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with rheumatoid arthritis: A meta-analysis update.
Elshazli R; Settin A
Immunobiology; 2015 Aug; 220(8):1012-24. PubMed ID: 25963842
[TBL] [Abstract][Full Text] [Related]
26. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.
Gourh P; Agarwal SK; Martin E; Divecha D; Rueda B; Bunting H; Assassi S; Paz G; Shete S; McNearney T; Draeger H; Reveille JD; Radstake TR; Simeon CP; Rodriguez L; Vicente E; Gonzalez-Gay MA; Mayes MD; Tan FK; Martin J; Arnett FC
J Autoimmun; 2010 Mar; 34(2):155-62. PubMed ID: 19796918
[TBL] [Abstract][Full Text] [Related]
27. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
[TBL] [Abstract][Full Text] [Related]
28. Protein tyrosine phosphatase non-receptor type 22 (PTPN22) +1858 C>T gene polymorphism in Egyptian cases with rheumatoid arthritis.
Salama A; Elshazli R; Elsaid A; Settin A
Cell Immunol; 2014 Jul; 290(1):62-5. PubMed ID: 24880676
[TBL] [Abstract][Full Text] [Related]
29. Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele.
Balada E; Villarreal-Tolchinsky J; Ordi-Ros J; Labrador M; Serrano-Acedo S; Martinez-Lostao L; Vilardell-Tarrés M
Tissue Antigens; 2006 Nov; 68(5):432-8. PubMed ID: 17092257
[TBL] [Abstract][Full Text] [Related]
30. The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.
López-Cano DJ; Cadena-Sandoval D; Beltrán-Ramírez O; Barbosa-Cobos RE; Sánchez-Muñoz F; Amezcua-Guerra LM; Juárez-Vicuña Y; Aguilera-Cartas MC; Moreno J; Bautista-Olvera J; Valencia-Pacheco G; López-Villanueva RF; Ramírez-Bello J
Inflamm Res; 2017 Sep; 66(9):775-781. PubMed ID: 28500376
[TBL] [Abstract][Full Text] [Related]
31. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.
Kokkonen H; Johansson M; Innala L; Jidell E; Rantapää-Dahlqvist S
Arthritis Res Ther; 2007; 9(3):R56. PubMed ID: 17553139
[TBL] [Abstract][Full Text] [Related]
32. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
[TBL] [Abstract][Full Text] [Related]
33. PTPN22 R620W polymorphism in the ANCA-associated vasculitides.
Martorana D; Maritati F; Malerba G; Bonatti F; Alberici F; Oliva E; Sebastio P; Manenti L; Brugnano R; Catanoso MG; Fraticelli P; Guida G; Gregorini G; Possenti S; Moroni G; Leoni A; Pavone L; Pesci A; Sinico RA; Di Toma L; D'Amico M; Tumiati B; D'Ippolito R; Buzio C; Neri TM; Vaglio A
Rheumatology (Oxford); 2012 May; 51(5):805-12. PubMed ID: 22237046
[TBL] [Abstract][Full Text] [Related]
34. HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies.
Morel PA; Chang HJ; Wilson JW; Conte C; Falkner D; Tweardy DJ; Medsger TA
Hum Immunol; 1995 Jan; 42(1):35-42. PubMed ID: 7751158
[TBL] [Abstract][Full Text] [Related]
35. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
36. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
[TBL] [Abstract][Full Text] [Related]
37. The R620W C/T polymorphism of the gene PTPN22 is associated with SLE independently of the association of PDCD1.
Reddy MV; Johansson M; Sturfelt G; Jönsen A; Gunnarsson I; Svenungsson E; Rantapää-Dahlqvist S; Alarcón-Riquelme ME
Genes Immun; 2005 Dec; 6(8):658-62. PubMed ID: 16052172
[TBL] [Abstract][Full Text] [Related]
38. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.
Satoh M; Akizuki M; Kuwana M; Mimori T; Yamagata H; Yoshida S; Homma M; Yamamoto T; Sasazuki T
J Rheumatol; 1994 Jan; 21(1):111-4. PubMed ID: 8151564
[TBL] [Abstract][Full Text] [Related]
39. HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma).
Kuwana M; Okano Y; Kaburaki J; Inoko H
Ann Rheum Dis; 1995 Dec; 54(12):983-7. PubMed ID: 8546531
[TBL] [Abstract][Full Text] [Related]
40. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody.
Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S
Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
